Furthermore, fasting insulin, HOMA-IR, and chemerin might be predictors of MS in MHMO, but this finding has to be confirmed in larger longitudinal studies and adjusted for potential confounders in further studies. This evidence concerns the gene RARRES2 and myeloid sarcoma.